Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

BackgroundGastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide treatm...

ver descrição completa

Detalhes bibliográficos
Principais autores: Sejeong Park, So Young Park, Yu Jin Kim, Soo Min Hong, Suk Chon, Seungjoon Oh, Jeong-taek Woo, Sung-Woon Kim, Young Seol Kim, Sang Youl Rhee
Formato: Artigo
Idioma:English
Publicado em: Korean Diabetes Association 2016-04-01
coleção:Diabetes & Metabolism Journal
Assuntos:
Diabetes mellitus, type 2
Gastrointestinal diseases
Rebamipide
Acesso em linha:https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-240.pdf

Internet

https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-240.pdf

Registros relacionados